Case Western Reserve University, in collaboration with NDI Medical LLC, SPR Therapeutics and Valtronic, has been awarded a $3 million grant from the Ohio Third Frontier Commission to commercialize a neurostimulation technology platform designed to treat multiple clinical indications, including pain and muscle paralysis.
Case Western Reserve has been developing the technology for the past decade. The neurostimulation implantable devices stimulate muscles paralyzed by spinal damage and enable individuals to move their arms or legs.
“This is an important investment and collaboration for the neurodevice industry, as well as the State of Ohio,” Geoff Thrope, chief executive officer and co-founder of NDI Medical, stated in a press release. “This platform technology will enable us to develop advanced treatments for spinal cord injury, chronic pain and a host of other indications as well as create new neurostimulation companies and jobs in Ohio.”